Tenderwize
Back to tender search

Open house discount agreement Brodalumab

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Feb 03, 2028 · 535 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Brodalumab, ATC L04AC12

60/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

60 / 100

Complexity

20 / 100

Risk factors

Lack of estimated value or volume – unknown revenue potential.

Submission requirements (paper vs electronic) may cause delays if not followed precisely.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Mar 2028
  • Supply of pharmaceutical products containing Brodalumab (ATC L04AC12)
  • Discount agreements under §130c SGB V with AOK Bayern
Show full summary

This is an open-house model (not a formal procurement procedure) by AOK Bayern for non-exclusive discount agreements on the active substance Brodalumab (ATC L04AC12). All qualified pharmaceutical companies can join on identical terms. Contracts run from earliest 01.04.2026 to 31.03.2028, with rolling monthly entry. No estimated value provided. The notice is published for transparency but does not constitute a competitive tender.

Risks

Lack of estimated value or volume – unknown revenue potential.

Submission requirements (paper vs electronic) may cause delays if not followed precisely.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submission of signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria; no selection is made under the open-house model.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house discount agreement Brodalumab

Non-exclusive discount agreements for pharmaceutical products containing Brodalumab (ATC L04AC12) with AOK Bayern. Open to all interested pharmaceutical companies meeting eligibility criteria. Contracts are identical and non-negotiable.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Mar 2026 - Mar 2028

Category

Pharmaceutical products

Award Criteria

No award criteria; no selection is made under the open-house model.

Deadline

Deadline Feb 03, 2028

Procurement Details

Publication date
15 Feb 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
107840-2026

Documents (2)

Similar tenders